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Introduction {#sec001}
============

Hypoxic-ischemia (HI) encephalopathy in neonates is a problem of enormous public health importance \[[@pone.0123585.ref001], [@pone.0123585.ref002]\]. Most of the survivors have neurodevelopmental sequela, including cerebral palsy and cognitive/behavioural/attentional deficits, especially in developing countries \[[@pone.0123585.ref001], [@pone.0123585.ref002]\]. There are few clinically successful strategies for neuroprotection once damage has occurred \[[@pone.0123585.ref003], [@pone.0123585.ref004]\].

Neurogenesis occurs in two regions of the adult rodent brain, the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampus dentate gyrus \[[@pone.0123585.ref005]\]. The persistence of neurogenesis throughout the lifetime raises the possibility that resident neural stem cells (NSCs) can mount a regenerative response to replace neurons that are lost upon brain injury. NSCs give rise to the three main cerebral cell types, which are neurons, astrocytes, and oligodendrocytes \[[@pone.0123585.ref006]\]. Previous studies have shown that endogenous neurogenesis increases in the immature rat brain in response to hypoxic-ischemic insult \[[@pone.0123585.ref007]--[@pone.0123585.ref009]\], which may serve to rescue neuronal loss and restore cognitive function after brain injury \[[@pone.0123585.ref010]\].

Periostin (POSTN; also PN or OSF-2) is a secreted extracellular matrix glycoprotein with a role in cell adhesion \[[@pone.0123585.ref011], [@pone.0123585.ref012]\]. POSTN is transiently expressed in multiple tissues, including the CNS, during early development. In the mouse CNS, POSTN expression spans from embryonic day 12.5 (E12.5) to 19.5 (E19.5) \[[@pone.0123585.ref013]\], a period that coincides with a critical period for neuron maturation and axon extension. Increased expression of POSTN after injury has been found in several adult tissues, such as fractured-bone-infarcted myocardial tissue and tissue undergoing cutaneous wound healing \[[@pone.0123585.ref014]--[@pone.0123585.ref016]\]. Delivery of recombinant POSTN has also been shown to promote cardiomyocyte proliferation and to improve cardiac remodeling \[[@pone.0123585.ref017], [@pone.0123585.ref018]\]. These data suggest an important role for POSTN in tissue repair and regeneration. Moreover, POSTN contains four domains that share homology with the insect growth cone guidance protein fasciclin I, suggesting a role for POSTN in neurite outgrowth \[[@pone.0123585.ref019]\]. Recently, POSTN has been shown to be re-expressed in the CNS after stroke and to reduce infarct volume when administered via intracerebroventricular injection \[[@pone.0123585.ref020]\]. From the above viewpoint, we hypothesize that POSTN may play an important role in brain repair and function recovery after hypoxic-ischemic injury.

Therefore, the purpose of the present study was to test the influence of POSTN deficiency on NSC proliferation and differentiation into neurons, and to examine the role(s) of POSTN in cultured NSCs and in neonatal rat brain after hypoxic-ischemic injury. The results indicate that POSTN is robustly expressed in differentiating NSCs, and stimulates NSC proliferation and differentiation *in vitro* and *in vivo*. POSTN treatment also rescued the cognitive deficits associated with hypoxia-ischemia (HI). These findings reveal novel functions of POSTN in the developing rodent brain, and offer a potential avenue for therapeutic intervention after HI-induced brain injury.

Materials and Methods {#sec002}
=====================

Animal surgery and HI induction {#sec003}
-------------------------------

This study was conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All protocols were approved by Clinical Pharmacology Ethics Committee of Fudan University, Pediatrics Ethics Committee in Shanghai. *POSTN* ^*+/-*^ mice were purchased from Jackson Laboratory (Stock No.009067; B6:129-POSTN^tm1Jmol/^J; Heterozygous X Heterozygous). We interbred mice that were heterozygous carriers of this mutation and obtained wild-type (*POSTN* ^*+/+*^) and homozygous mutant (*POSTN* ^*-/-*^) offspring with the expected Mendelian distribution. DNA analyzed by PCR was used to identify POSTN heterozygous (*POSTN* ^*+/-*^ *)*, homozygous mutant (*POSTN* ^*-/-*^) and wild-type (*POSTN* ^*+/+*^)mice. The pups were nursed by their biological mothers until they were sacrificed. The pups were given intraperitoneal injection with freshly prepared 5-bromodeoxyuridine (BrdU; Sigma, 50 mg/kg body weight) once daily until the time of sacrifice \[[@pone.0123585.ref021]\].

HI was induced in neonatal Sprague-Dawley rats at postnatal day 7 (P7) as previously described \[[@pone.0123585.ref022]--[@pone.0123585.ref024]\]. Briefly, male or female pups were anesthetized with isoflurane, and the left common carotid artery was isolated and ligated with surgical silk. The surgical procedure was completed within 5 min and the pups were allowed to recover for 2 h in a temperature-controlled incubator. Animals were then placed in a container perfused with a humidified gas mixture (8% oxygen-nitrogen) at 37°C for 2 h. Control animals were not subjected to the surgical procedure. The animals were randomly assigned to four groups, where control and HI-subjected pups were injected with either PBS or POSTN following the recovery period (Sham + PBS, Sham + POSTN, HI + PBS, and HI + POSTN). Specifically, 2 μl PBS or recombinant human POSTN (100 μg/ml; Abcam, UK) was injected into the lateral ventricles as previously described \[[@pone.0123585.ref025]\]. The pups were nursed by their biological mothers until they were sacrificed at 7 or 14 days after HI. To label proliferating cells, the pups were given intraperitoneal injection with freshly prepared 5-bromodeoxyuridine (BrdU; 50 mg/kg body weight) once daily after HI until the time of sacrifice \[[@pone.0123585.ref021]\].

Tissue preparation and immunofluorescence {#sec004}
-----------------------------------------

Both wild-type (*POSTN* ^*+/+*^) and homozygous mutant (*POSTN* ^*-/-*^) mice were deeply anesthetized on P7, 14, 21, and 28; and SD rat pups from control and experimental groups were deeply anesthetized at 7 and 14 days after HI, and perfused with 4% paraformaldehyde in 0.1M PBS. The brains were removed and immersion-fixed in the same solution at 4°C for 24 h, then dehydrated in a graded series of sucrose (20%, 30% in PBS) until they were saturated. Coronal sections were cut on a freezing microtome (Jung Histocut Model 820-II; Leica, Nussloch, Germany) at a thickness of 30 μm from Bregma 1.60 to −4.80 mm, and stored at −20°C in cryoprotectant solution. For combined immunodetection of BrdU and cell type-specific markers in NSCs, sections were first incubated with anti-BrdU antibody (1:250; Santa Cruz, Sc-32323, USA) for 2 h at 37°C, then overnight at 4°C. Sections were rinsed with PBS, then incubated with anti-mouse IgG-Cy3 (1:500; Invitrogen, USA) for 45 min at 37°C, followed by an overnight incubation with anti-nestin (1:100; Millipore, MAB353, USA), anti-NeuN (1:200; Millipore, MAB377, USA), anti-MAP2 (1:200; MAB5622, Millipore, USA), or anti-GFAP (1:150; AB5804, Millipore, USA) at 4°C. After rinsing in PBS, sections were incubated with anti-rabbit IgG-FITC (1:500; Invitrogen) or anti-sheep IgG-FITC (1:500; Invitrogen) for 45 min at 37°C. Sections were washed and mounted onto glass slides using fluorescence mounting medium (Vector Laboratories, USA). Fluorescence was detected with excitation/emission wavelengths of 570/576 nm (Rhodamine) and 490/525 nm (FITC) using a Zeiss 510 confocal laser scanning microscope (Zeiss, Thornwood, USA).

Neural Stem Cell culture {#sec005}
------------------------

NSCs were obtained from dissociated embryonic cortex dissected from C57BL/6 mice at E12.5 \[[@pone.0123585.ref026]\]. The tissue was triturated and filtered before centrifugation, and cell suspensions were plated at a density of 2 × 10^6^ cells/ml with DMEM/F12 medium containing 1% N2, 2% B27 (Gibco, Carlsbad, USA), EGF (20 ng/ml; R&D Systems), and bFGF (20 ng/ml; R&D Systems). Differentiation was induced by replacing the culture medium with a DMEM/F12 medium containing 1% fetal bovine serum (Gibco) in addition to 1% N2 and 2% B27, but lacking growth factors. The cells were treated with BrdU at 3, 5, and 7 days after switching to differentiation medium (growth factor withdrawal).

POSTN mRNA quantification by real-time PCR {#sec006}
------------------------------------------

500 ng of total RNA was extracted from the NSCs at 0 h, 48 h, and 5 days after differentiation using TRIZOL. The RNA was reverse-transcribed using PrimeScript RT Master Mix (Takara Bio Inc., Shiga, Japan) according to the manufacturer's instructions. 1 μl of cDNA was used in 20 μl reactions that consisted of 1× SYBR Green Realtime PCR Master Mix (Toyobo, Osaka, Japan), 0.5 μM forward and reverse primers, and nuclease-free water. GAPDH expression levels were determined in parallel as an internal control for all the samples. PCR reactions were performed using Qiagen Rotor-Gene Q (Qiagen, USA). Primers for POSTN and GAPDH mRNA detection were designed with PrimerBank. The sequences were as follows: for POSTN, 5'-GGGAGCCACTACCACTCAG-3' (forward) and 5'-GTACGTGTAT GACCCTTTTCCTT-3' (reverse); and for GAPDH, 5'-ACGGCCGCATCTTCTTGT GCAGTG-3' (forward) and 5'-GGCCTTGACTGTGCCGTTGAATTT-3' (reverse). All reactions were performed in triplicate, and relative quantification values were calculated using the ΔCt method (95% CI) with calibration to 0 h samples. All primer sets were subjected to a dissociation curve analysis and produced single peaks on a derivative plot of raw fluorescence.

Morris water maze test {#sec007}
----------------------

Animals subjected to the HI surgical procedure described above were tested for cognitive performance in the Morris water maze at P42--46 (n = 20 animals per group). The water maze (Med Associates Inc., Georgia, USA) (diameter: 1.6 m; height: 0.5 m; distance from floor to bottom of maze: 0.45 m) was filled with water (21 ± 1°C). The black platform (diameter: 0.12 m; height: 0.30 m) was submerged to 1 cm below the water surface. The memory tests were performed as previously described \[[@pone.0123585.ref027]\]. For the navigation test, the animals underwent four trials daily with different starting points for four consecutive days. Animals escaping the platform were restricted within 120 s, and were allowed to rest on the platform for 15 s. After removal of the platform on the fifth day, animals were subjected to a 60 s space probe trial. The escape latency, swimming distance, number of platform crossings, and the percentage of time spent in the target quadrant were recorded. Data were analyzed using a tracking program (DigBehv-MWM; Shanghai Jiliang Software Technology Co. Ltd., Shanghai, China).

Statistical methods {#sec008}
-------------------

Three consecutive sections were selected for the quantification of NSCs in immunostained tissue. Double-labeled cells in the SVZ and SGZ were counted using Stereo Investigator 6.5 software (MicroBrightfield Inc., Williston, USA) using the Optical Fractionator probe at 20× objective (n = 8--10 animals per group) \[[@pone.0123585.ref028]\]. For cultured NSCs, six images per treatment condition from randomly selected regions of the coverslip were acquired using a 40× objective lens, and double-labeled cells were counted manually. Data from three independent experiments were pooled and expressed as mean ± SEM. Differences between groups were analyzed by ANOVA followed by the Student-Newman-Keuls test. Statistical significance was set at *P* \< 0.05.

Results {#sec009}
=======

POSTN expression was increased when accompanied by NSC differentiation {#sec010}
----------------------------------------------------------------------

POSTN expression in mouse CNS spans from E12.5 to E19.5 \[[@pone.0123585.ref013]\]. To investigate the manner of POSTN expression during NSC differentiation, NSCs isolated from E12.5 mice were cultured in proliferation and differentiation media successively. The levels of POSTN gene expression at 0 h, 48 h and 5 days after differentiation were determined by quantitative real-time PCR. POSTN mRNA levels were significantly increased at 48 h and 5 days following NSC differentiation compared to proliferating NSCs (0 h) ([Fig 1A](#pone.0123585.g001){ref-type="fig"}). We also detected the POSTN protein expression in mouse NSCs. Western blot analysis showed that POSTN was stably expressed in mouse NSCs ([Fig 1B](#pone.0123585.g001){ref-type="fig"}).

![Expression of POSTN mRNA in cultured NSCs and the effect of POSTN deficiency on NSC proliferation and differentiation in SGZ.\
A: Compared to POSTN expression in proliferating NSCs (0 h), POSTN levels were increased at 48 h and 5 days following differentiation. B: POSTN is stably expressed in mouse neural stem cells. C: The protein expression of POSTN was decreased in the brain of *POSTN* ^*+/-*^ mice (KO) compared to wild-type mice (WT). D-E: The number of proliferating neurons was decreased at P7, 14, 21 and 28 in POSTN null mice. F-G: The number of proliferating NSCs was decreased in POSTN null mice at P7, 14, 21 and 28. Cells were quantified per mm^3^ and data are shown as mean ± SEM. \* *P* \< 0.05; \*\* *P* \< 0.01; n = 9 animals per group. Scale bar = 50μm.](pone.0123585.g001){#pone.0123585.g001}

Defects in proliferation and Differentiation of NSCs in *POSTN* null mouse {#sec011}
--------------------------------------------------------------------------

*POSTN* ^*+/-*^ mice were purchased from Jackson Laboratory. The absence of protein expression was comfirmed by western blot analysis on P7 developing brain extracts ([Fig 1C](#pone.0123585.g001){ref-type="fig"}). To examine the influence of POSTN deficiency on proliferation and differentiation of neural stem cells, *POSTN* ^*+/-*^ mice were intercrossed to obtain homozygous *POSTN* ^*-/-*^ mice. BrdU and Nestin double-immunostaining was used to label the proliferating NSCs. BrdU and NeuN double-immunostaining was used to label new mature proliferating neurons. Compared to the *POSTN* ^*+/+*^ mice, both proliferating mature neurons (Fig [1D](#pone.0123585.g001){ref-type="fig"} and [1E](#pone.0123585.g001){ref-type="fig"}) and neural stem cells (Fig [1F](#pone.0123585.g001){ref-type="fig"} and [1G](#pone.0123585.g001){ref-type="fig"}) in the dentate gyrus (DG) of the hippocampus were significantly decreased in the *POSTN* ^*-/-*^ mice at P7, 14, 21 and 28.

POSTN promotes NSC proliferation and differentiation *in vitro* {#sec012}
---------------------------------------------------------------

To investigate the effects of POSTN on NSC proliferation and differentiation *in vitro*, NSCs were cultured in the presence of 50 ng/mL POSTN. Proliferating NSCs were identified as cells double-positive for BrdU and Nestin (BrdU^+^/Nestin^+^), while BrdU^+^/MAP2^+^ and BrdU^+^/GFAP^+^ cells represented NSCs differentiating into neurons and astrocytes, respectively. NSCs cultured in the presence of POSTN showed a prominent enhancement in proliferation (Fig [2A](#pone.0123585.g002){ref-type="fig"} and [2B](#pone.0123585.g002){ref-type="fig"}). Proliferation rates were significantly increased at 5 and 7 days after NSC differentiation compared to control NSCs ([Fig 2C](#pone.0123585.g002){ref-type="fig"}). Similarly, the numbers of neurons ([Fig 2D](#pone.0123585.g002){ref-type="fig"}--[2F](#pone.0123585.g002){ref-type="fig"}) and astrocytes ([Fig 2G](#pone.0123585.g002){ref-type="fig"}--[2I](#pone.0123585.g002){ref-type="fig"}) were increased after POSTN treatment compared to controls, although these increases were not statistically significant until 7 days after differentiation.

![Effects of POSTN on NSC proliferation and differentiation *in vitro*.\
A--C: The presence of POSTN (+POSTN) increases the number of proliferating NSCs at 5 and 7 days after plating, as evidenced by an increase in BrdU^+^/Nestin^+^ double-positive cells. D--F: The fraction of NSCs undergoing differentiation into neurons (BrdU^+^/MAP2^+^ cells) increases at 7 days after plating when POSTN is present. G--I: The fraction of NSCs undergoing differentiation into astrocytes (BrdU^+^/GFAP^+^ cells) increased at 7 days after plating in the presence of POSTN. The ratio of double-positive cells to the total number of cells is shown as mean ± SEM (\* *P* \< 0.05 from three independent experiments). Scale bar = 100 μm.](pone.0123585.g002){#pone.0123585.g002}

POSTN promotes NSC proliferation and differentiation in the SVZ and SGZ in the neonatal brain after HI {#sec013}
------------------------------------------------------------------------------------------------------

Previous studies found that POSTN expression was increased in different tissues after injury \[[@pone.0123585.ref014]--[@pone.0123585.ref016]\]. Also, POSTN exhibited neuroprotective function in a transient middle cerebral artery occlusion model \[[@pone.0123585.ref020]\]. To examine the effects of POSTN on NSC proliferation and differentiation *in vivo*, recombinant POSTN was injected into the lateral ventricles of neonates following HI injury. Proliferating and differentiating NSCs were identified by combined immunodetection of BrdU and either Nestin, MAP2, or GFAP in the SVZ and SGZ. HI injury caused significant increases in the proliferation and differentiation of NSCs (HI+PBS) compared to animals that were not subjected to hypoxic-ischemic conditions (Sham+ PBS) (Fig [3](#pone.0123585.g003){ref-type="fig"} and [4](#pone.0123585.g004){ref-type="fig"}). However, the number of BrdU^+^/Nestin^+^ cells in the SVZ was markedly increased after POSTN treatment (HI + POSTN) at 7 and 14 days ([Fig 3A](#pone.0123585.g003){ref-type="fig"}--[3C](#pone.0123585.g003){ref-type="fig"}). In contrast, treatment of POSTN in the absence of HI injury (Sham +POSTN) had no effect on NSC proliferation. Similar increases in BrdU^+^/MAP2^+^ ([Fig 3D](#pone.0123585.g003){ref-type="fig"}--[3F](#pone.0123585.g003){ref-type="fig"}) and BrdU^+^/GFAP^+^ ([Fig 3G](#pone.0123585.g003){ref-type="fig"}--[3I](#pone.0123585.g003){ref-type="fig"}) double-positive cells were observed after POSTN treatment, reflecting an increase in differentiation of NSCs into neurons and astrocytes, respectively. Consistent observations were also made for NSCs in the SGZ ([Fig 4](#pone.0123585.g004){ref-type="fig"}). The number of BrdU^+^/Nestin^+^ cells in the HI + POSTN group was significantly higher than those in HI + PBS-treated animals ([Fig 4A](#pone.0123585.g004){ref-type="fig"}--[4C](#pone.0123585.g004){ref-type="fig"}), demonstrating that NSC proliferation was stimulated by POSTN. The numbers of differentiated neurons (BrdU^+^/MAP2^+^ cells; [Fig 4D](#pone.0123585.g004){ref-type="fig"}--[4F](#pone.0123585.g004){ref-type="fig"}) and astrocytes (BrdU^+^/GFAP^+^ cells; [Fig 4G](#pone.0123585.g004){ref-type="fig"}--[4I](#pone.0123585.g004){ref-type="fig"}) were also higher in the HI + POSTN group at 7 and 14 days after HI compared to controls, consistent with a general effect of promoting differentiation rather than of specifying a particular cell type.

![Effects of POSTN on NSC proliferation and differentiation in the rat SVZ following HI.\
Hypoxic-ischemic injury (HI + PBS) stimulates NSC proliferation (A--C; BrdU^+^/Nestin^+^ cells) and differentiation into neurons (D--F; BrdU^+^/MAP2^+^ cells) and astrocytes (G--I; BrdU^+^/GFAP^+^ cells) at 7 and 14 days, but the effect is potentiated when POSTN is present (HI + POSTN). Cells were quantified per mm^3^ and data are shown as mean ± SEM. \* or \# *P* \< 0.05; \*\* or \#\# *P* \< 0.01; n = 8 animals per group. Scale bar = 100 μm.](pone.0123585.g003){#pone.0123585.g003}

![Effects of POSTN on NSC proliferation and differentiation in the SGZ following HI.\
Hypoxic-ischemic injury (HI + PBS) stimulates NSC proliferation (A--C; BrdU^+^/Nestin^+^ cells) and differentiation into neurons (D--F; BrdU^+^/MAP2^+^ cells) and astrocytes (G--I; BrdU^+^/GFAP^+^ cells) at 7 and 14 days, but the effect is potentiated when POSTN is present (HI + POSTN). Cells were quantified per mm^3^ and data are shown as mean ± SEM. \* or \# *P* \< 0.05; \*\* or \#\# *P* \< 0.01; n = 8 animals per group. Scale bar = 100 μm.](pone.0123585.g004){#pone.0123585.g004}

Cognitive enhancement following POSTN treatment {#sec014}
-----------------------------------------------

To examine the effect of POSTN on cognitive function, which is impaired by hypoxic-ischemic injury, animals were tested in the Morris water maze at P42--46. In the navigation trials, it was observed that HI + PBS-treated control animals had greater escape latency ([Fig 5A](#pone.0123585.g005){ref-type="fig"}) and swimming distance ([Fig 5B](#pone.0123585.g005){ref-type="fig"}) compared to animals that had not undergone HI surgery, indicating a learning deficit resulting from HI. However, HI + POSTN-treated animals showed significant improvement in escape latency and swimming distance, which increased by 20% and 30%, respectively (Fig [5A](#pone.0123585.g005){ref-type="fig"} and [5B](#pone.0123585.g005){ref-type="fig"}). Treatment of POSTN in control animals that were not subjected to HI (Sham + POSTN) did not enhance performance over basal levels (Sham + PBS), indicating that the effects of POSTN on cognitive function were specific to the conditions produced by HI. In the probe trials, animals in the HI + PBS group spent less time in the target quadrant ([Fig 5C](#pone.0123585.g005){ref-type="fig"}) and engaged in fewer platform crossings ([Fig 5D](#pone.0123585.g005){ref-type="fig"}) as compared to control animals. Treatment of POSTN in HI animals restored the number of platform crossings and the time spent in the target quadrant to values comparable to those of control animals.

![Effect of POSTN on promoting cognitive deficits after HI.\
Perinatal POSTN injection (HI + POSTN) rescues cognitive deficits caused by HI (HI + PBS) at P42--46, as assessed by escape latency (A), swimming distance (B), percentage of time spent in the target quadrant (C), and number of platform site crossovers (D) in the Morris water maze test. Data are shown as mean ± SEM. \* or \# *P* \< 0.05; \*\* *P* \< 0.01; n = 20 animals per group.](pone.0123585.g005){#pone.0123585.g005}

Discussion {#sec015}
==========

Periostin is characterized as a matricellular protein with known functions in different physiological and pathological conditions \[[@pone.0123585.ref029]\], especially in tissue remodeling as a response to insult/injury. Our present study demonstrated that POSTN mRNA was stably expressed in NSCs, and deficiency of POSTN depressed the proliferation and differentiation of NSCs. The proliferation and differentiation of cultured NSCs were stimulated after POSTN treatment. POSTN promoted the neurogenesis and function recovery in HI brain injury. Taken together, these findings indicate that POSTN plays an important role in brain development and brain injury remodeling.

Emerging evidences have shown that during embryogenesis and in the neonate, expressions of POSTN isoforms show a specific temporal and spatial pattern, which suggests different functions in tissue development and remodeling \[[@pone.0123585.ref029]\]. Zhu *et al*. found that the effect of POSTN on bone formation and remodeling is through an increase in osteoblast proliferation, differentiation, adhesion, and survival \[[@pone.0123585.ref030]\]. Furthermore, POSTN has been shown to be expressed at basal levels in healthy human skin but localized to the extracellular compartment during tissue remodeling involved in wound repair \[[@pone.0123585.ref031]\]. POSTN plays a key role in cardiovascular development, however, the expression of POSTN can be rapidly increased in response to injury \[[@pone.0123585.ref032]--[@pone.0123585.ref035]\]. The previous studies have shown that POSTN has an effect on promoting non-neuronal cell genesis in development and pathology \[[@pone.0123585.ref030], [@pone.0123585.ref036], [@pone.0123585.ref037]\]. However, our present study suggested that POSTN also expresses in NSCs and plays important roles in brain development and remodeling.

POSTN also has a neuroprotective role *in vitro* and *in vivo* during cerebral ischemia \[[@pone.0123585.ref038]\]. Shimamura *et al*. reported that POSTN expressed in various cells, such as reactive astrocytes/microglia, fibroblasts, and neuronal progenitor cells, and might be associated with pathophysiology in post-ischemic inflammation and neurogenesis \[[@pone.0123585.ref039]\]. However, there are no reports that suggest a role of POSTN in the neonatal hypoxic-ischemic rodent brains, especially a potential role in stimulating proliferation of NSCs and promoting neurogenesis following injury.

In the present study, it was observed that POSTN mRNA levels were increased upon NSC differentiation. These data suggest that even under non-pathological conditions, endogenous POSTN is associated with NSC differentiation. Indeed, POSTN treatment significantly enhanced NSC differentiation into neurons and astrocytes *in vitro* ([Fig 2](#pone.0123585.g002){ref-type="fig"}). Consistent with results from previous studies \[[@pone.0123585.ref040], [@pone.0123585.ref041]\], following hypoxic-ischemic injury, POSTN treatment in neonatal rat brains also enhanced the proliferation and differentiation of NSCs in two neurogenic regions, the SVZ ([Fig 3](#pone.0123585.g003){ref-type="fig"}) and the SGZ ([Fig 4](#pone.0123585.g004){ref-type="fig"}). HI in itself increases NSC self-renewal, differentiation and maturation \[[@pone.0123585.ref042]\]. However, endogenous neurogenesis following HI injury is ineffective on repairing damage; studies have shown that the capacity for neuronal replacement in the adult brain is very low, with only an estimated 0.2% to 10% of lost neurons being replaced \[[@pone.0123585.ref043], [@pone.0123585.ref044]\]. The results described herein suggest that POSTN has an effect on stimulating neuron production following HI beyond basal levels.

Factors that promote NSC proliferation and differentiation may be useful as potential therapeutic tools for treating brain injury \[[@pone.0123585.ref045], [@pone.0123585.ref046]\]. In the present study, POSTN significantly enhanced NSC proliferation and differentiation when applied exogenously; moreover, Morris water maze test showed that POSTN-treated animals had a significant improvement in spatial learning and memory, which were impaired by HI, compared to untreated control animals. These results indicate that POSTN may reverse cognitive deficits resulting from HI injury by stimulating NSC self-renewal and neuronal and glial cell differentiation.

Periostin is thought to play a critical role in cell apoptosis. Recent study has found that periostin silencing significantly increased the number of apoptotic colon cancer cells through supressing the PI3K/Akt/survivin pathway \[[@pone.0123585.ref047]\]. Aukkarasongsup *et al*. \[[@pone.0123585.ref048]\] also demonstrated that the percentage of apoptotic periodontal ligament cells was markedly decreased under hypoxia after treatment with recombinant human POSTN via TGF-β signaling. However, other study has shown that POSTN deficiency decreased the hypoxia-stimulated proliferation, but had no effect on cell apoptosis \[[@pone.0123585.ref049]\]. In our study, we tested the anti-apoptosis effect of POSTN on neurons and found that POSTN protected neurons from apoptosis under hypoxia conditions (data not shown). The anti-apoptosis effect of POSTN on NSCs under hypoxia and the related molecular mechanism need the further study.

Conclusions {#sec016}
===========

In summary, POSTN treatment significantly enhanced NSC proliferation and stimulated the production of neurons and astrocytes both *in vitro* and *in vivo*. Furthermore, POSTN improved cognitive functions that were compromised by HI-induced brain injury. Additional studies need to be undertaken in order to examine the mechanisms underlying POSTN-induced stimulation of neurogenesis for these findings to be useful in the development of clinical approaches for the treatment of perinatal HI, and improving the prognosis of HI encephalopathy and other types of brain injury.
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